scispace - formally typeset
A

Alexei V. Galatenko

Researcher at Moscow State University

Publications -  31
Citations -  273

Alexei V. Galatenko is an academic researcher from Moscow State University. The author has contributed to research in topics: Human leukocyte antigen & Medicine. The author has an hindex of 8, co-authored 28 publications receiving 158 citations. Previous affiliations of Alexei V. Galatenko include National Research University – Higher School of Economics & LSI Corporation.

Papers
More filters
Journal ArticleDOI

Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.

TL;DR: In this paper, the authors explored whether HLA class I genotypes can be associated with the critical course of Coronavirus Disease-19 by searching possible connections between genotypes of deceased patients and their age at death.
Journal ArticleDOI

Highly informative marker sets consisting of genes with low individual degree of differential expression.

TL;DR: A method for construction of highly informative gene combinations aimed at the maximization of the cumulative informative power was developed and sets of 2–5 genes efficiently predicting recurrence for ER-positive breast cancer patients were identified.
Journal ArticleDOI

Changes in the Level of Circulating hsa-miR-297 and hsa-miR-19b-3p miRNA Are Associated with Generalization of Prostate Cancer.

TL;DR: Diagnostic classification of plasma specimens from patients with non-metastatic and metastatic prostate cancer based on pairs of miRNA that have no individual diagnostic significance found hsa-miR-19b-3p and hSA-mi R-297 demonstrated highest sensitivity and specificity.
Patent

Unified architecture for crypto functional units

TL;DR: In this paper, a unified CFU block architecture is proposed for advanced communication processors to provide parallel and concurrent processing of multiple crypto operations/transactions within high-speed hardware to support different security standards (e.g., IPsec, 3GPP).
Journal ArticleDOI

Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules

TL;DR: The majority of HLA alleles and haplotypes was not significantly affected by the mutations, suggesting the maintenance of effective T-cell immunity against the Omicron and Delta variants.